TC
AMRX icon

Tejara Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Tejara Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-86,824
Closed -$551K – 59
2024
Q2 		$551K Buy
+86,824
New +$551K 0.2% 57
2023
Q4 		– Sell
-96,672
Closed -$408K – 69
2023
Q3 		$408K Buy
+96,672
New +$361K 0.23% 53

Other funds holding AMRX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Tejara Capital's AMRX Position: Q3 2024 in Review

Tejara Capital sold out of Amneal Pharmaceuticals (AMRX) in Q3 2024, closing a stake of 86,824 shares — an estimated $551K sold.

Tejara Capital first reported a position in AMRX in Q3 2023 and held it in 2 quarters. The position peaked at $551K in Q2 2024. 182 funds tracked by Wall St. Rank hold AMRX as of Q3 2024.

  • Tejara Capital reported no remaining Amneal Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Tejara Capital sold 86,824 Amneal Pharmaceuticals shares in Q3 2024, an estimated $551K.
  • Tejara Capital first reported a position in Amneal Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • Tejara Capital's Amneal Pharmaceuticals position peaked at $551K in Q2 2024.
  • 182 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2024.

Based on Tejara Capital's 13F filing for Q3 2024, filed 13 Nov 2024.